Search

1. Tirzepatide for type 2 diabetes: final report

Author(s):

Lin, Grace A., author
Nikitin, Dmitriy, author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jon D., author
Brouwer, Elizabeth, author
Chen, Yilin, MPH, author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022

Subject(s):

Diabetes Mellitus, Type 2 -- drug therapy
Gastric Inhibitory Polypeptide -- therapeutic use
Hypoglycemic Agents -- therapeutic use
Incretins -- therapeutic use
United States

2. Insulin degludec (Tresiba®, Novo Nordisk A/S) for the treatment of diabetes: effectiveness, value, and value-based price benchmarks : final report

Author(s):

Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Chapman, Rick M., author
Shore, Karen K., author
Weissberg, Jed, author
Pearson, Steven D., author

Publication:

[Boston, MA] : Institute for Clinical and Economic Review, March 14, 2016

Subject(s):

Blood Glucose -- drug effects
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 2 -- drug therapy
Hypoglycemia -- prevention & control
Hypoglycemic Agents -- therapeutic use
Insulin, Long-Acting -- administration & dosage
Insulin, Long-Acting -- therapeutic use
United States